Core Insights - The Joint Corp. has elected Christopher M. Grandpre to its board of directors to support long-term growth objectives including new clinic openings, system-wide sales, comparable sales, and Adjusted EBITDA [1][2] Company Overview - The Joint Corp. is the largest provider of chiropractic care in the U.S. through The Joint Chiropractic network, focusing on making chiropractic care accessible and affordable without the need for insurance [5] - The company operates over 950 locations nationwide and has more than 14 million patient visits annually, positioning itself as a leader in the chiropractic industry [5] Leadership and Expertise - Christopher M. Grandpre brings over 30 years of experience in multi-branded franchise companies and M&A investment banking, having served as chairman of Empower Brands, which has sales exceeding $1.5 billion [3][4] - Grandpre's background includes founding Outdoor Living Brands and holding executive roles at various financial institutions, providing a unique perspective to The Joint's leadership [3][4] Business Model and Strategy - The Joint Corp. revolutionized chiropractic care access with its retail healthcare business model introduced in 2010, focusing on convenience and affordability for patients [5] - The company is recognized in various industry rankings, including Franchise Times' "Top 400" and Entrepreneur's "Franchise 500," highlighting its growth and innovation in the franchise sector [5]

Core Insights - Sernova Biotherapeutics has formed a Clinical Advisory Board to guide the development of its Cell Pouch Bio-hybrid Organ as a potential functional cure for type 1 diabetes (T1D) [1][7] Group 1: Clinical Advisory Board Composition - The board consists of five members, chaired by Dr. Robert Gabbay, who has extensive experience in diabetes care and research [2] - Other notable members include: - Dr. Mark Atkinson, a leading researcher in T1D with over 750 publications [3] - Dr. Melena Bellin, an expert in islet cell transplantation for T1D [4] - Dr. Andrew Posselt, a surgeon-scientist specializing in transplant immunology [5] - Dr. Holger Russ, who focuses on regenerative medicine and autoimmune type 1 diabetes [6] Group 2: Company Overview and Technology - Sernova Biotherapeutics is a clinical-stage company developing regenerative medicine therapeutics, specifically the Cell Pouch integrated with human donor cells or stem-cell derived islet-like clusters [8] - The Cell Pouch is designed to create bio-hybrid organs that restore or enhance organ function, initially targeting T1D and thyroid disorders [9]

 Presentations by leading siRNA CDMOs, Bachem, Nitto Avecia, and ST Pharm, highlight performance and transferability of Codexis double-stranded RNA ligases Management to host conference call today at 8 am Eastern Time to discuss data REDWOOD CITY, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, presented data at the TIDES USA annual meeting in San Diego, California. Codexis’ ...

Core Insights - Enthusiast Gaming has announced a strategic partnership with Mediacube, enhancing its media inventory and access to a larger network of YouTube creators [1][2] - The partnership aims to provide brands with expanded access to Gen Z and Millennial audiences through premium advertising opportunities [2][4] - Mediacube selected Enthusiast Gaming for its proven ability to help brands authentically engage in the gaming space, creating new monetization paths for creators [3] Company Overview - Enthusiast Gaming is a leading gaming media and entertainment company in North America, focusing on connecting video game enthusiasts and esports fans [5][6] - The company operates on five core pillars: creators, content, communities, games, and experiences, offering integrated brand solutions for marketers [5][6] - Enthusiast Gaming continues to grow its network, reflecting the diversity and scale of gaming enthusiasts today [5][6]

Dovre Group Plc Inside information May 22, 2025, at 2 pm Markku Taskinen has been appointed as the CEO of Suvic Oy, a subsidiary of Dovre Markku Taskinen has been appointed as the new CEO of Suvic Oy, succeeding Ville Vesanen. He will assume the position at the latest on September 22, 2025. The planning of the future composition and role structure of the company’s management team will begin immediately, and the outcome will be announced by autumn. Taskinen joins Suvic from the position of CEO at Hartela Poh ...

MONTREAL, May 22, 2025 (GLOBE NEWSWIRE) -- Troilus Gold Corp. (“Troilus” or the “Company”, TSX: TLG; OTCQX: CHXMF; FSE: CM5R) is pleased to report additional positive drill results from the Southwest Zone (“Southwest”), at its Troilus Project located in northcentral Quebec, Canada. The results herein are part of the company’s 2025 drill campaign (outlined in the February 4, 2025 press release), focused on identifying and delineating higher-grade mineralization and enhancing confidence in the block model wit ...

Core Insights - Tilray Medical has launched its cannabis brand Good Supply in Germany, aiming to provide affordable and reliable medical cannabis options for patients [1][2][3] - The introduction of Good Supply reflects Tilray's commitment to enhancing patient care and empowering healthcare professionals with innovative medical cannabis solutions [2][3] - Good Supply offers a variety of cannabis strains, available in both 15g and 500g, catering to the diverse needs of patients [2][7] Company Overview - Tilray Medical is a leading player in the global medical cannabis industry, with operations in Canada, Portugal, and Germany, and is recognized for its commitment to quality and innovation [3][4] - The company has established itself as a trusted supplier of medical cannabis, with a portfolio that includes multiple brands designed to meet patient needs worldwide [4][6] - Tilray Brands, Inc. operates as a global lifestyle and consumer packaged goods company, focusing on cannabis, wellness, and entertainment, with a mission to inspire joy and create memorable experiences [6]

Group 1: Project Overview - Accelsius has been selected as a key contributor to the U.S. Department of Energy's ARPA-E COOLERCHIPS project, focusing on developing a next-generation hybrid cooling architecture for data centers [1][3] - The project aims to reduce total cooling energy consumption to less than 5% of a data center's IT load while maintaining reliability and enabling high-density computing [3] Group 2: Technology and Contributions - Accelsius will provide its proprietary MR250, a multi-rack, in-row, 250kW two-phase Coolant Distribution Unit (2P CDU), for system-level testing at the UT Arlington campus [2] - The MR250 is expected to be generally available by late 2025, enhancing the project's test infrastructure [2] Group 3: Collaboration and Impact - The collaboration between Accelsius and The University of Texas at Arlington is expected to advance the understanding and benchmarking of two-phase, direct-to-chip cooling technologies [3][4] - Industry leaders express excitement about the potential impact of this collaboration on U.S. leadership in next-generation data center efficiency [4] Group 4: Company Background - Accelsius, founded by Innventure, Inc. (NASDAQ:INV), specializes in advanced cooling solutions that help data center and edge operators achieve business, financial, and sustainability goals [5] - The company's NeuCool platform offers best-in-class thermal efficiencies through a safe, two-phase liquid cooling system scalable from single racks to entire data centers [5]

NORWALK, Conn., May 22, 2025 (GLOBE NEWSWIRE) -- FactSet (NYSE: FDS | NASDAQ: FDS), a global financial digital platform and enterprise solutions provider, today announced that Chief Executive Officer Phil Snow will participate in a fireside chat at the Bernstein 41st Annual Strategic Decisions Conference in New York on Thursday, May 29, 2025, at 8:00 a.m. Eastern Time. To access the live webcast, please visit the event page. By the end of the day, an audio replay of the webcast will be available for 90 days ...

SALT LAKE CITY, Utah, May 22, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), a leader in advanced ceramics for medical device and other technical applications, announced the issuance of International Patent No. 7635292, which covers novel agricultural uses of the Company’s silicon nitride (Si₃N₄) particularly in plant protection and antimicrobial treatment. This patent, combined with issued U.S. Patent No. 11,591,217, creates a family of patents focused on addre ...